Adding Roche's immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread ...

Swiss healthcare firm Roche Diagnostics has launched a new diagnostics legal entity in Nigeria to deepen access to innovative healthcare and improve diagnostics capacity across West Africa.According ...

Peter Ahnesorg is the new head of Roche Hungary’s pharmaceuticals division, replacing Raffaella Claudia Bondi, who led the ...

The European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature ...

The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA ; Evrysdi offers the same efficacy and safety demo ...

The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in ...

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...